In conclusion, we show here that cytotoxicity of AdV-TRAIL can be enhanced in TRAIL-resistant and TRAIL-sensitive melanoma cells by co-silencing of the antiapoptotic Bcl-2 protein Mcl-1 by activation of apoptosis and necrosis. Here, MCL1 is linked to melanoma.